Literature DB >> 19420084

Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection.

Barry Rockx1, Tracey Baas, Gregory A Zornetzer, Bart Haagmans, Timothy Sheahan, Matthew Frieman, Matthew D Dyer, Thomas H Teal, Sean Proll, Judith van den Brand, Ralph Baric, Michael G Katze.   

Abstract

Several respiratory viruses, including influenza virus and severe acute respiratory syndrome coronavirus (SARS-CoV), produce more severe disease in the elderly, yet the molecular mechanisms governing age-related susceptibility remain poorly studied. Advanced age was significantly associated with increased SARS-related deaths, primarily due to the onset of early- and late-stage acute respiratory distress syndrome (ARDS) and pulmonary fibrosis. Infection of aged, but not young, mice with recombinant viruses bearing spike glycoproteins derived from early human or palm civet isolates resulted in death accompanied by pathological changes associated with ARDS. In aged mice, a greater number of differentially expressed genes were observed than in young mice, whose responses were significantly delayed. Differences between lethal and nonlethal virus phenotypes in aged mice could be attributed to differences in host response kinetics rather than virus kinetics. SARS-CoV infection induced a range of interferon, cytokine, and pulmonary wound-healing genes, as well as several genes associated with the onset of ARDS. Mice that died also showed unique transcriptional profiles of immune response, apoptosis, cell cycle control, and stress. Cytokines associated with ARDS were significantly upregulated in animals experiencing lung pathology and lethal disease, while the same animals experienced downregulation of the ACE2 receptor. These data suggest that the magnitude and kinetics of a disproportionately strong host innate immune response contributed to severe respiratory stress and lethality. Although the molecular mechanisms governing ARDS pathophysiology remain unknown in aged animals, these studies reveal a strategy for dissecting the genetic pathways by which SARS-CoV infection induces changes in the host response, leading to death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19420084      PMCID: PMC2704758          DOI: 10.1128/JVI.00127-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

Review 1.  Inflamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology.

Authors:  S Salvioli; M Capri; S Valensin; P Tieri; D Monti; E Ottaviani; C Franceschi
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

2.  Fatal pulmonary failure attributable to viral pneumonia with human herpes virus 6 (HHV6) in a young immunocompetent woman.

Authors:  Johannes Merk; Franz Xaver Schmid; Martin Fleck; Stephan Schwarz; Con Lehane; Stephan Boehm; Bernd Salzberger; Dietrich E Birnbaum
Journal:  J Intensive Care Med       Date:  2005 Sep-Oct       Impact factor: 3.510

3.  Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs.

Authors:  Amy C Sims; Ralph S Baric; Boyd Yount; Susan E Burkett; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Generation of C5a in the absence of C3: a new complement activation pathway.

Authors:  Markus Huber-Lang; J Vidya Sarma; Firas S Zetoune; Daniel Rittirsch; Thomas A Neff; Stephanie R McGuire; John D Lambris; Roscoe L Warner; Michael A Flierl; Laszlo M Hoesel; Florian Gebhard; John G Younger; Scott M Drouin; Rick A Wetsel; Peter A Ward
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

6.  Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus.

Authors:  John C Kash; Terrence M Tumpey; Sean C Proll; Victoria Carter; Olivia Perwitasari; Matthew J Thomas; Christopher F Basler; Peter Palese; Jeffery K Taubenberger; Adolfo García-Sastre; David E Swayne; Michael G Katze
Journal:  Nature       Date:  2006-09-27       Impact factor: 49.962

7.  Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement.

Authors:  Panisadee Avirutnan; Nuntaya Punyadee; Sansanee Noisakran; Chulaluk Komoltri; Somchai Thiemmeca; Kusuma Auethavornanan; Aroonroong Jairungsri; Rattiyaporn Kanlaya; Nattaya Tangthawornchaikul; Chunya Puttikhunt; Sa-Nga Pattanakitsakul; Pa-Thai Yenchitsomanus; Juthathip Mongkolsapaya; Watchara Kasinrerk; Nopporn Sittisombut; Matthias Husmann; Maria Blettner; Sirijitt Vasanawathana; Sucharit Bhakdi; Prida Malasit
Journal:  J Infect Dis       Date:  2006-03-09       Impact factor: 5.226

8.  Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome.

Authors:  Nelson Leung-Sang Tang; Paul Kay-Sheung Chan; Chun-Kwok Wong; Ka-Fai To; Alan Ka-Lun Wu; Ying-Man Sung; David Shu-Cheong Hui; Joseph Jao-Yiu Sung; Christopher Wai-Kei Lam
Journal:  Clin Chem       Date:  2005-09-29       Impact factor: 8.327

9.  Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS.

Authors:  L He; Y Ding; Q Zhang; X Che; Y He; H Shen; H Wang; Z Li; L Zhao; J Geng; Y Deng; L Yang; J Li; J Cai; L Qiu; K Wen; X Xu; S Jiang
Journal:  J Pathol       Date:  2006-11       Impact factor: 7.996

Review 10.  Angiotensin-converting enzyme 2 in lung diseases.

Authors:  Keiji Kuba; Yumiko Imai; Josef M Penninger
Journal:  Curr Opin Pharmacol       Date:  2006-04-03       Impact factor: 5.547

View more
  94 in total

1.  Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.

Authors:  Matthew Frieman; Boyd Yount; Sudhakar Agnihothram; Carly Page; Eric Donaldson; Anjeanette Roberts; Leatrice Vogel; Becky Woodruff; Diana Scorpio; Kanta Subbarao; Ralph S Baric
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.

Authors:  Meagan Bolles; Damon Deming; Kristin Long; Sudhakar Agnihothram; Alan Whitmore; Martin Ferris; William Funkhouser; Lisa Gralinski; Allison Totura; Mark Heise; Ralph S Baric
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques.

Authors:  Li Liu; Qiang Wei; Xavier Alvarez; Haibo Wang; Yanhua Du; Hua Zhu; Hong Jiang; Jingying Zhou; Pokman Lam; Linqi Zhang; Andrew Lackner; Chuan Qin; Zhiwei Chen
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  Increased viral loads and exacerbated innate host responses in aged macaques infected with the 2009 pandemic H1N1 influenza A virus.

Authors:  Laurence Josset; Flora Engelmann; Kristen Haberthur; Sara Kelly; Byung Park; Yoshi Kawoaka; Adolfo García-Sastre; Michael G Katze; Ilhem Messaoudi
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

Review 5.  Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Authors:  Henok Kessete Afewerky
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-07

Review 6.  Comparative pathogenesis and systems biology for biodefense virus vaccine development.

Authors:  Gavin C Bowick; Alan D T Barrett
Journal:  J Biomed Biotechnol       Date:  2010-06-06

7.  Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus.

Authors:  Barry Rockx; Eric Donaldson; Matthew Frieman; Timothy Sheahan; Davide Corti; Antonio Lanzavecchia; Ralph S Baric
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

8.  Exacerbated innate host response to SARS-CoV in aged non-human primates.

Authors:  Saskia L Smits; Anna de Lang; Judith M A van den Brand; Lonneke M Leijten; Wilfred F van IJcken; Marinus J C Eijkemans; Geert van Amerongen; Thijs Kuiken; Arno C Andeweg; Albert D M E Osterhaus; Bart L Haagmans
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

9.  Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease.

Authors:  Christine L Wohlford-Lenane; David K Meyerholz; Stanley Perlman; Haixia Zhou; Dat Tran; Michael E Selsted; Paul B McCray
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

Review 10.  The application of genomics to emerging zoonotic viral diseases.

Authors:  Bart L Haagmans; Arno C Andeweg; Albert D M E Osterhaus
Journal:  PLoS Pathog       Date:  2009-10-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.